+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Psoriasis Treatment Market by Drug Type (Systemic Treatments, Topical Treatments), Route of Administration (Injectable, Oral, Topical), Disease Type, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Psoriasis Treatment Market by Drug Type (Systemic Treatments, Topical Treatments), Route of Administration (Injectable, Oral, Topical), Disease Type, End-User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Psoriasis Treatment Market by Drug Type (Systemic Treatments, Topical Treatments), Route of Administration (Injectable, Oral, Topical), Disease Type, End-User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 194 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090282
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The psoriasis treatment market is experiencing pivotal changes, spurred by clinical innovation, evolving patient pathways, and ongoing regulatory realignment. Senior decision-makers are navigating an increasingly complex ecosystem in which operational agility and targeted therapeutic development are shaping tomorrow’s market landscape.

Market Snapshot: Growth Trajectory and Psoriasis Treatment Market Metrics

The psoriasis treatment market grew from USD 19.54 billion in 2024 to USD 21.19 billion in 2025. It is expected to maintain significant momentum with a CAGR of 8.71%, reaching USD 32.26 billion by 2030. This robust expansion is fueled by new biologics, evolving patient management strategies, and ongoing commercialization efforts across multiple geographies.

Scope & Segmentation: Comprehensive Analysis of Treatment Channels, End-User Profiles, and Regional Coverage

  • Drug Type: Systemic treatments (biologics such as IL-17 inhibitors, IL-23 inhibitors, T-cell inhibitors, TNF-alpha inhibitors), oral medications, phototherapy, and a wide array of topical solutions including calcineurin inhibitors, corticosteroids, retinoids, and vitamin D analogues.
  • Route of Administration: Injectable, oral, and topical delivery methods reflective of varying disease severity and patient preferences.
  • Disease Type: Focus on erythrodermic, guttate, inverse, plaque, and pustular psoriasis, each requiring tailored clinical approaches.
  • End-User: Engagement across ambulatory surgical centers, hospitals, specialty clinics, and expanding homecare settings ensures a holistic patient care continuum.
  • Distribution Channel: Accessibility via offline outlets including hospital and retail pharmacies, as well as a steadily rising online presence targeting convenience-driven segments.
  • Geographical Coverage: In-depth analysis across the Americas (including United States, Canada, Mexico, Brazil, Argentina), EMEA (such as United Kingdom, Germany, France, UAE, Saudi Arabia, South Africa), and Asia-Pacific markets (like China, India, Japan, Australia, South Korea).
  • Company Coverage: Detailed competitive insights on leading participants including AbbVie, Almirall, Amgen, Bausch Health, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celltrion, Eli Lilly, Fresenius Kabi, GlaxoSmithKline, Johnson & Johnson, LEO Pharma, Lupin, Merck, Mitsubishi Tanabe, Novartis, Pfizer, Samsung Bioepis, Sanofi, Sun Pharma, Takeda, UCB, and Viatris.

Key Takeaways for Senior Decision-Makers

  • Precision medicine and real-world data are fundamentally influencing therapy selection and enhancing sustained disease management.
  • Digital health integration is optimizing patient engagement and adherence, with mobile applications and remote monitoring tools enabling data-driven interventions.
  • Biosimilar competition is intensifying, compelling manufacturers to differentiate through patient support programs, innovative contracting, and clinical value demonstration.
  • Segment-specific adoption—whether by drug class, administration route, or care setting—directly impacts product lifecycle strategies and market access planning.
  • Regional infrastructure and reimbursement models continue to drive disparate rates of innovation and therapy availability, demanding tailored commercialization tactics.
  • Strategic collaborations—from R&D alliances to digital health partnerships—are critical for pipeline acceleration and portfolio diversification.

Tariff Impact: Navigating Evolving US Trade Policies

Recent tariff reforms in the United States have led to higher costs for biologic APIs and select intermediates, prompting manufacturers to reconfigure supply networks, invest in domestic operations, and consider dual-sourcing strategies. Stakeholders are increasingly adopting scenario planning and public-private partnerships to enhance supply chain resilience and maintain stable patient access across volatile trade environments.

Methodology & Data Sources

This report utilizes a dual-research framework, combining primary interviews with dermatologists, healthcare executives, and patient focus groups, with exhaustive secondary analysis of regulatory filings, real-world datasets, peer-reviewed literature, and corporate disclosures. Scenario modeling and thematic coding ensure actionable findings underpinned by diverse and cross-validated datasets.

Why This Report Matters: Strategic Value for Leadership Teams

  • Enables evidence-based portfolio planning by mapping market drivers, segment preferences, and clinical adoption barriers with clarity.
  • Supports informed risk mitigation through clear assessment of tariff impact, supply chain vulnerabilities, and flexible procurement strategies.
  • Guides cross-functional collaboration for market entry, product positioning, and operational optimization in both developed and emerging regions.

Conclusion

The psoriasis treatment market is defined by rapid clinical advancement and increasing operational complexity. Decision-makers who integrate flexible strategies, data-driven insights, and cross-sector partnerships will be positioned to deliver value and sustain growth in this evolving space.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Focus on personalized medicine through genetic and biomarker profiling to optimize psoriasis treatment outcomes
5.2. Growing uptake of IL-17 and IL-23 inhibitor biologics in treatment protocols for moderate to severe psoriasis
5.3. Increasing integration of digital health platforms and teledermatology for remote psoriasis management
5.4. Emergence of biosimilar biologics driving cost competition and expanded patient access to psoriasis therapies
5.5. Development of oral small molecule inhibitors targeting tyrosine kinases as alternative to injectable treatments
5.6. Implementation of patient-centric support programs leveraging mobile apps to improve adherence in chronic psoriasis care
5.7. Advancements in topical nanoformulations to enhance drug penetration and reduce systemic side effects in psoriasis
5.8. Expansion of combination therapy regimens combining biologics with phototherapy for enhanced efficacy in refractory cases
5.9. Regulatory approval of novel PDE4 inhibitors for mild to moderate psoriasis offering new non-biologic options
5.10. Heightened emphasis on real world evidence studies to assess long-term safety and cost effectiveness of psoriasis drugs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Psoriasis Treatment Market, by Drug Type
8.1. Introduction
8.2. Systemic Treatments
8.2.1. Biologics
8.2.1.1. IL-17 Inhibitors
8.2.1.2. IL-23 Inhibitors
8.2.1.3. T-cell Inhibitors
8.2.1.4. TNF-alpha Inhibitors
8.2.2. Oral Medications
8.2.3. Phototherapy
8.3. Topical Treatments
8.3.1. Calcineurin Inhibitors
8.3.2. Corticosteroids
8.3.3. Retinoids
8.3.4. Vitamin D Analogues
9. Psoriasis Treatment Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Psoriasis Treatment Market, by Disease Type
10.1. Introduction
10.2. Erythrodermic Psoriasis
10.3. Guttate Psoriasis
10.4. Inverse Psoriasis
10.5. Plaque Psoriasis
10.6. Pustular Psoriasis
11. Psoriasis Treatment Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers (ASCs)
11.3. Homecare Settings
11.4. Hospitals
11.5. Specialty Clinics
12. Psoriasis Treatment Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.2.1. Hospital Pharmacies
12.2.2. Retail Pharmacies
12.3. Online
13. Americas Psoriasis Treatment Market
13.1. Introduction
13.2. Argentina
13.3. United States
13.4. Canada
13.5. Mexico
13.6. Brazil
14. Europe, Middle East & Africa Psoriasis Treatment Market
14.1. Introduction
14.2. Germany
14.3. Israel
14.4. Turkey
14.5. United Arab Emirates
14.6. Netherlands
14.7. Qatar
14.8. Switzerland
14.9. Italy
14.10. Poland
14.11. Spain
14.12. Egypt
14.13. Denmark
14.14. Russia
14.15. Finland
14.16. Saudi Arabia
14.17. France
14.18. Norway
14.19. Nigeria
14.20. Sweden
14.21. United Kingdom
14.22. South Africa
15. Asia-Pacific Psoriasis Treatment Market
15.1. Introduction
15.2. Malaysia
15.3. Taiwan
15.4. Indonesia
15.5. Australia
15.6. Vietnam
15.7. Japan
15.8. South Korea
15.9. Singapore
15.10. India
15.11. Thailand
15.12. Philippines
15.13. China
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Almirall, S.A.
16.3.3. Amgen Inc.
16.3.4. Bausch Health Companies Inc.
16.3.5. Biogen Inc.
16.3.6. Boehringer Ingelheim GmbH
16.3.7. Bristol-Myers Squibb Company
16.3.8. Celltrion, Inc.
16.3.9. Eli Lilly and Company
16.3.10. Fresenius Kabi AG
16.3.11. GlaxoSmithKline plc
16.3.12. Johnson & Johnson Services, Inc.
16.3.13. LEO Pharma A/S
16.3.14. Lupin Limited
16.3.15. Merck & Co., Inc.
16.3.16. Mitsubishi Tanabe Pharma Corporation
16.3.17. Novartis AG
16.3.18. Pfizer Inc.
16.3.19. Samsung Bioepis Co., Ltd.
16.3.20. Sanofi S.A.
16.3.21. Sun Pharmaceutical Industries Ltd.
16.3.22. Takeda Pharmaceutical Company Limited
16.3.23. UCB S.A.
16.3.24. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PSORIASIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. PSORIASIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. PSORIASIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PSORIASIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PSORIASIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PSORIASIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PSORIASIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PSORIASIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY IL-17 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY IL-23 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY T-CELL INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY TNF-ALPHA INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY VITAMIN D ANALOGUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ERYTHRODERMIC PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY GUTTATE PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY INVERSE PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY PUSTULAR PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL PSORIASIS TREATMENT MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES PSORIASIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. CANADA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 75. CANADA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 76. CANADA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 77. CANADA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. CANADA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. CANADA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. CANADA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 82. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 84. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 88. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. MEXICO PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. BRAZIL PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 111. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 112. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 113. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 114. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 115. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. GERMANY PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 119. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 121. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. ISRAEL PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 128. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 129. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 130. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 131. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 132. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 133. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 149. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 150. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 151. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 152. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. NETHERLANDS PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 155. QATAR PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. QATAR PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 157. QATAR PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 158. QATAR PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 159. QATAR PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. QATAR PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 161. QATAR PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. QATAR PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. QATAR PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 164. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 173. ITALY PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. ITALY PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 175. ITALY PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 176. ITALY PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 177. ITALY PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 178. ITALY PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 179. ITALY PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. ITALY PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ITALY PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 182. POLAND PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 184. POLAND PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 185. POLAND PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 186. POLAND PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 187. POLAND PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. POLAND PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. POLAND PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. POLAND PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 191. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 192. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 193. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 194. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 195. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 196. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. SPAIN PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 200. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 201. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 202. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 203. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 204. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 205. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 206. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. EGYPT PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 209. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 211. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 214. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 215. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. DENMARK PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 218. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 219. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 220. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 221. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 222. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 223. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 224. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 225. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. RUSSIA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 227. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 228. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 229. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 230. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 231. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 233. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 234. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. FINLAND PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 236. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 238. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 245. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 246. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 247. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 248. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 249. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 250. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 251. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 252. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. FRANCE PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 254. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 255. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 256. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 257. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 258. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 259. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 260. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. NORWAY PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 272. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 273. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 274. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 275. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 276. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 277. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 288. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 290. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 292. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 294. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 295. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 296. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 297. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 298. SOUTH AFRICA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC PSORIASIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 318. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 319. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 320. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 321. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 322. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 323. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 324. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 325. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 326. TAIWAN PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 328. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 329. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 330. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 331. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 332. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 333. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. INDONESIA PSORIASIS TREATMENT MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
TABLE 336. AUSTRALIA PSORIASIS TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 337. AUSTRALIA PSORIASIS TREATMENT MARKET SIZE, BY SYSTEMIC TREATMENTS, 2018-2030 (USD MILLION)
TABLE 338. AUSTRALIA PSORIASIS TREATMENT MARKET SIZE, BY BIOLOGICS, 2018-2030 (USD MILLION)
TABLE 339. AUSTRALIA PSORIASIS TREATMENT MARKET SIZE, BY TOPICAL T

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Psoriasis Treatment market report include:
  • AbbVie Inc.
  • Almirall, S.A.
  • Amgen Inc.
  • Bausch Health Companies Inc.
  • Biogen Inc.
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Celltrion, Inc.
  • Eli Lilly and Company
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • LEO Pharma A/S
  • Lupin Limited
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Novartis AG
  • Pfizer Inc.
  • Samsung Bioepis Co., Ltd.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • UCB S.A.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 21.19 Billion
Forecasted Market Value ( USD ) by 2030 $ 32.26 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Psoriasis Therapeutics Market by Therapeutic Class (Biologics, Phototherapy, Small Molecules), Route Of Administration (Injectable, Oral, Topical), Distribution Channel, End User, Disease Severity, Patient Age Group - Global Forecast 2025-2030 - Product Image

Psoriasis Therapeutics Market by Therapeutic Class (Biologics, Phototherapy, Small Molecules), Route Of Administration (Injectable, Oral, Topical), Distribution Channel, End User, Disease Severity, Patient Age Group - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Psoriasis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Psoriasis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Psoriasis Drugs Market by Drug Class (Biologics, Small Molecules), Route Of Administration (Injectable, Oral, Topical), Patient Severity, Psoriasis Type, Patient Type, Distribution Channel, Treatment Setting - Global Forecast 2025-2030 - Product Image

Psoriasis Drugs Market by Drug Class (Biologics, Small Molecules), Route Of Administration (Injectable, Oral, Topical), Patient Severity, Psoriasis Type, Patient Type, Distribution Channel, Treatment Setting - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Psoriasis Drugs Market Size, Share & Trends Analysis Report by Class, Treatment (Topicals, Systemic, Biologics), Route of Administration (Oral, Parenteral), Distribution Channel, and Region with Growth Forecasts, 2025-2030 - Product Image

Psoriasis Drugs Market Size, Share & Trends Analysis Report by Class, Treatment (Topicals, Systemic, Biologics), Route of Administration (Oral, Parenteral), Distribution Channel, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Systemic Psoriasis Therapeutics - Global Strategic Business Report - Product Image

Systemic Psoriasis Therapeutics - Global Strategic Business Report

  • Report
  • 192 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.